Resmed (RSMDF) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to $392.6 million.
- Resmed's Income from Continuing Operations rose 1391.99% to $392.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 1899.33%. This contributed to the annual value of $1.4 billion for FY2025, which is 3719.79% up from last year.
- Resmed's Income from Continuing Operations amounted to $392.6 million in Q4 2025, which was up 1391.99% from $348.5 million recorded in Q3 2025.
- In the past 5 years, Resmed's Income from Continuing Operations registered a high of $392.6 million during Q4 2025, and its lowest value of -$78.5 million during Q1 2021.
- Over the past 5 years, Resmed's median Income from Continuing Operations value was $227.3 million (recorded in 2022), while the average stood at $247.8 million.
- In the last 5 years, Resmed's Income from Continuing Operations plummeted by 14810.74% in 2021 and then skyrocketed by 32809.6% in 2022.
- Over the past 5 years, Resmed's Income from Continuing Operations (Quarter) stood at $201.8 million in 2021, then increased by 11.48% to $224.9 million in 2022, then decreased by 7.16% to $208.8 million in 2023, then soared by 65.05% to $344.6 million in 2024, then rose by 13.92% to $392.6 million in 2025.
- Its Income from Continuing Operations was $392.6 million in Q4 2025, compared to $348.5 million in Q3 2025 and $379.7 million in Q2 2025.